Tenaya Therapeutics Inc (TNYA)
4.42
+0.24
(+5.74%)
USD |
NASDAQ |
May 22, 16:00
4.42
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Cash from Investing (TTM): 36.16M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 36.16M |
| December 31, 2023 | 48.72M |
| September 30, 2023 | 69.61M |
| June 30, 2023 | 70.15M |
| March 31, 2023 | 75.28M |
| December 31, 2022 | 83.65M |
| September 30, 2022 | 15.10M |
| Date | Value |
|---|---|
| June 30, 2022 | -184.36M |
| March 31, 2022 | -217.81M |
| December 31, 2021 | -238.56M |
| September 30, 2021 | -184.16M |
| June 30, 2021 | -15.90M |
| March 31, 2021 | -13.65M |
| December 31, 2020 | -7.01M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-238.56M
Minimum
Dec 2021
83.65M
Maximum
Dec 2022
-33.06M
Average
4.044M
Median
Cash from Investing (TTM) Benchmarks
| Biomarin Pharmaceutical Inc | -95.47M |
| Corvus Pharmaceuticals Inc | 10.93M |
| Solid Biosciences Inc | -66.06M |
| Dyne Therapeutics Inc | -123.59M |
| Sana Biotechnology Inc | 32.06M |